565 related articles for article (PubMed ID: 21690031)
1. [Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].
Bayard S; Cochen De Cock V; Dauvillers Y
Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):227-35. PubMed ID: 21690031
[TBL] [Abstract][Full Text] [Related]
2. Medication-related impulse control and repetitive behaviors in Parkinson's disease.
Voon V; Potenza MN; Thomsen T
Curr Opin Neurol; 2007 Aug; 20(4):484-92. PubMed ID: 17620886
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced impulse control disorders in Parkinson's disease.
Reiff J; Jost WH
J Neurol; 2011 May; 258(Suppl 2):S323-7. PubMed ID: 21560063
[TBL] [Abstract][Full Text] [Related]
4. Impulsive and compulsive behaviors in Parkinson's disease.
Evans AH; Strafella AP; Weintraub D; Stacy M
Mov Disord; 2009 Aug; 24(11):1561-70. PubMed ID: 19526584
[TBL] [Abstract][Full Text] [Related]
5. Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease.
Fenu S; Wardas J; Morelli M
Behav Pharmacol; 2009 Sep; 20(5-6):363-79. PubMed ID: 19724195
[TBL] [Abstract][Full Text] [Related]
6. Impact of dopamine agonists on compulsive behaviors: a case series of pramipexole-induced pathological gambling.
Kolla BP; Mansukhani MP; Barraza R; Bostwick JM
Psychosomatics; 2010; 51(3):271-3. PubMed ID: 20484726
[TBL] [Abstract][Full Text] [Related]
7. Compulsive habits in restless legs syndrome patients under dopaminergic treatment.
Pourcher E; Rémillard S; Cohen H
J Neurol Sci; 2010 Mar; 290(1-2):52-6. PubMed ID: 19969309
[TBL] [Abstract][Full Text] [Related]
8. Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson's disease.
Kimber TE; Thompson PD; Kiley MA
J Clin Neurosci; 2008 Feb; 15(2):205-8. PubMed ID: 18068992
[TBL] [Abstract][Full Text] [Related]
9. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS
Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
[TBL] [Abstract][Full Text] [Related]
10. Dopamine agonists and therapy compliance.
Grosset D
Neurol Sci; 2008 Dec; 29 Suppl 5():S375-6. PubMed ID: 19381766
[TBL] [Abstract][Full Text] [Related]
11. Medication-related impulse control and repetitive behaviors in Parkinson disease.
Voon V; Fox SH
Arch Neurol; 2007 Aug; 64(8):1089-96. PubMed ID: 17698698
[TBL] [Abstract][Full Text] [Related]
12. Dopamine agonist: pathological gambling and hypersexuality.
Prescrire Int; 2008 Oct; 17(97):200-1. PubMed ID: 19536937
[TBL] [Abstract][Full Text] [Related]
13. Impulse control disorders in Parkinson's disease: prevalence and possible risk factors.
Weintraub D
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S110-3. PubMed ID: 20082968
[TBL] [Abstract][Full Text] [Related]
14. Impulsive and compulsive behaviors in Parkinson's disease: a one-year follow-up study.
Ávila A; Cardona X; Martín-Baranera M; Bello J; Sastre F
J Neurol Sci; 2011 Nov; 310(1-2):197-201. PubMed ID: 21683375
[TBL] [Abstract][Full Text] [Related]
15. Compulsive eating and weight gain related to dopamine agonist use.
Nirenberg MJ; Waters C
Mov Disord; 2006 Apr; 21(4):524-9. PubMed ID: 16261618
[TBL] [Abstract][Full Text] [Related]
16. Pathological gambling associated with dopamine agonist use in restless legs syndrome.
Quickfall J; Suchowersky O
Parkinsonism Relat Disord; 2007 Dec; 13(8):535-6. PubMed ID: 17270485
[TBL] [Abstract][Full Text] [Related]
17. Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.
O'Sullivan SS; Evans AH; Lees AJ
CNS Drugs; 2009; 23(2):157-70. PubMed ID: 19173374
[TBL] [Abstract][Full Text] [Related]
18. Addiction-like manifestations and Parkinson's disease: a large single center 9-year experience.
Limotai N; Oyama G; Go C; Bernal O; Ong T; Moum SJ; Bhidayasiri R; Foote KD; Bowers D; Ward H; Okun MS
Int J Neurosci; 2012 Mar; 122(3):145-53. PubMed ID: 22023411
[TBL] [Abstract][Full Text] [Related]
19. Compulsive use of dopaminergic drug therapy in Parkinson's disease: reward and anti-reward.
Evans AH; Lawrence AD; Cresswell SA; Katzenschlager R; Lees AJ
Mov Disord; 2010 May; 25(7):867-76. PubMed ID: 20461804
[TBL] [Abstract][Full Text] [Related]
20. Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome.
Bayard S; Langenier MC; Dauvilliers Y
Sleep; 2013 Oct; 36(10):1501-7. PubMed ID: 24082309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
